↓ Skip to main content

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review

Overview of attention for article published in BMC Cancer, December 2014
Altmetric Badge

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review
Published in
BMC Cancer, December 2014
DOI 10.1186/1471-2407-14-966
Pubmed ID
Authors

Vishal Vashistha, David I Quinn, Tanya B Dorff, Siamak Daneshmand

Abstract

Although Muscle Invasive Bladder Cancer (MIBC) is increasing in incidence, treatment has largely remained limited to radical cystectomy with or without cisplatin-based neoadjuvant and/or adjuvant chemotherapy. We reviewed the current and recent clinical trials evaluating perioperative chemotherapy, targeted therapy, and novel therapeutic regimens for MIBC patients undergoing radical cystectomy.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
Uruguay 1 2%
Unknown 48 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 20%
Student > Postgraduate 6 12%
Student > Bachelor 6 12%
Student > Ph. D. Student 5 10%
Student > Master 4 8%
Other 11 22%
Unknown 8 16%
Readers by discipline Count As %
Medicine and Dentistry 30 60%
Agricultural and Biological Sciences 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Business, Management and Accounting 1 2%
Other 2 4%
Unknown 9 18%